134 related articles for article (PubMed ID: 25315847)
1. Racial differences in mantle cell lymphoma in the United States.
Wang Y; Ma S
BMC Cancer; 2014 Oct; 14():764. PubMed ID: 25315847
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in nasopharyngeal carcinoma in the United States.
Wang Y; Zhang Y; Ma S
Cancer Epidemiol; 2013 Dec; 37(6):793-802. PubMed ID: 24035238
[TBL] [Abstract][Full Text] [Related]
4. Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival.
Breen CT; Chao J; Mehra S; Kohli N
Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):412-419. PubMed ID: 34137303
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in Urinary Bladder Cancer in the United States.
Wang Y; Chang Q; Li Y
Sci Rep; 2018 Aug; 8(1):12521. PubMed ID: 30131523
[TBL] [Abstract][Full Text] [Related]
6. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
Wu XC; Andrews P; Chen VW; Groves FD
Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
[TBL] [Abstract][Full Text] [Related]
7. An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA.
Aschebrook-Kilfoy B; Caces DB; Ollberding NJ; Smith SM; Chiu BC
Leuk Lymphoma; 2013 Aug; 54(8):1677-83. PubMed ID: 23350889
[TBL] [Abstract][Full Text] [Related]
8. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States.
Rahman R; Schmaltz C; Jackson CS; Simoes EJ; Jackson-Thompson J; Ibdah JA
Cancer Med; 2015 Dec; 4(12):1863-70. PubMed ID: 26471963
[TBL] [Abstract][Full Text] [Related]
9. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
[TBL] [Abstract][Full Text] [Related]
10. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.
Zhou Y; Wang H; Fang W; Romaguer JE; Zhang Y; Delasalle KB; Kwak L; Yi Q; Du XL; Wang M
Cancer; 2008 Aug; 113(4):791-8. PubMed ID: 18615506
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in stage-specific gastric cancer: analysis of results from the Surveillance Epidemiology and End Results (SEER) program database.
Zhang G; Zhao X; Li J; Yuan Y; Wen M; Hao X; Li P; Zhang A
J Investig Med; 2017 Aug; 65(6):991-998. PubMed ID: 28442533
[TBL] [Abstract][Full Text] [Related]
12. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
13. Using primary site as a predictor of survival in mantle cell lymphoma.
Ambinder AJ; Shenoy PJ; Nastoupil LJ; Flowers CR
Cancer; 2013 Apr; 119(8):1570-7. PubMed ID: 23341329
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in six major subtypes of melanoma: descriptive epidemiology.
Wang Y; Zhao Y; Ma S
BMC Cancer; 2016 Aug; 16(1):691. PubMed ID: 27576582
[TBL] [Abstract][Full Text] [Related]
15. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
[TBL] [Abstract][Full Text] [Related]
18. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
Cohen JB; Han X; Jemal A; Ward EM; Flowers CR
Cancer; 2016 Aug; 122(15):2356-63. PubMed ID: 27153197
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma survival patterns by WHO subtype in the United States, 1973-2003.
Han X; Kilfoy B; Zheng T; Holford TR; Zhu C; Zhu Y; Zhang Y
Cancer Causes Control; 2008 Oct; 19(8):841-58. PubMed ID: 18365759
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data.
Su YC; Chiu BC; Li HJ; Yang WC; Chen TY; Yeh SP; Wang MC; Huang WT; Lee MY; Lin SF
PLoS One; 2022; 17(3):e0265543. PubMed ID: 35298555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
